TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34264696

Group type: EXPERIMENTAL
Intervention: Mindfulness-based mobile health (mHealth) intervention
Number of subjects: 114

Group type: COMPARATOR
Intervention: Social support-based mHealth control
Number of subjects: 114
Study: 33484240

Group type: EXPERIMENTAL
Intervention: EaseVRx (immersive pain relief skills VR program)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Sham VR (2D nature content delivered in a VR headset)
Number of subjects: 179
Study: 32087121

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Skin emollients (skin intervention group)
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Early complementary feeding (food intervention group)
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Combined skin and food interventions (combined intervention group)
Number of subjects: 2397
Study: 32274492

Group type: EXPERIMENTAL
Intervention: Sodium fluoride tooth protector combined with pit and fissure sealant
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pit and fissure sealant alone
Number of subjects: 200
Study: 35750321

Group type: EXPERIMENTAL
Intervention: Anchoring-endoscopic mucosal resection (A-EMR)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional endoscopic mucosal resection (C-EMR)
Number of subjects: 211
Study: 34622680

Group type: COMPARATOR
Intervention: Low-volume centers
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Intermediate-volume centers
Number of subjects: 1032

Group type: COMPARATOR
Intervention: High-volume centers
Number of subjects: 1032
Study: 36373323

Group type: EXPERIMENTAL
Intervention: NIR light treatment (1060-1080 nm and 800-820 nm) for 12 weeks
Number of subjects: 20
Study: 34339475

Group type: EXPERIMENTAL
Intervention: Six-minute walk test (6MWT)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Age, sex, mRS, and 6MWT
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Daily physical activity
Number of subjects: 92
Study: 32498216

Group type: EXPERIMENTAL
Intervention: Difensil Immuno (DI) 10 mL for 90 days
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Difensil Immuno (DI) 15 mL for 45 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 34633141

Group type: EXPERIMENTAL
Intervention: Evidence-based nursing intervention for 6 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 120
Study: 32475902

Group type: EXPERIMENTAL
Intervention: Repaglinide-based combination therapy with alogliptin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Miglitol-based combination therapy with alogliptin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Repaglinide monotherapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Miglitol monotherapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination therapy with alogliptin
Number of subjects: 18
Study: 32868595

Group type: EXPERIMENTAL
Intervention: Preterm Breastfeeding Assessment Tool (PBAT)
Number of subjects: 60
Study: 35945634

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (two times a week for 6 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study: 33769243

Group type: EXPERIMENTAL
Intervention: ZnCl2 (1.5 µg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Na2SeO3 (5 µg/l)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ZnCl2 + Na2SeO3 (1.5 µg/ml + 5 µg/l)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control maturation medium (basic medium)
Number of subjects: 0
Study: 32902561

Group type: EXPERIMENTAL
Intervention: Open-lung ventilation (recruitment maneuvers, PEEP = 8 cm H2O, low-tidal volume)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Open-lung ventilation
Number of subjects: 86
Study: 35747142

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (Engerix‐B, 20 μg/time) administered subcutaneously/intramuscularly at weeks 0, 4, and 24
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (blank control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (Engerix‐B)
Number of subjects: 200
Study: 34962665

Group type: EXPERIMENTAL
Intervention: SRP + diode laser (0.80W power, 940nm wavelength and 0.80J/s energy level)
Number of subjects: 40

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 40
Study: 35468736

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) program, 9 weeks
Number of subjects: 20
Study: 33031265

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block with ropivacaine (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 60
Study: 33495545

Group type: EXPERIMENTAL
Intervention: MDD participants
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo response in a sham-controlled trial of high-frequency repetitive transcranial magnetic stimulation
Number of subjects: 109
Study: 32807234

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35818255

Group type: EXPERIMENTAL
Intervention: Joint process location slip technique combined with percutaneous endoscopic lumbar disc discectomy
Number of subjects: 290

Group type: COMPARATOR
Intervention: Traditional intervertebral fenestration of nucleus pulposus
Number of subjects: 290
Study: 32511792

Group type: EXPERIMENTAL
Intervention: Prophylactic clipping (PC)
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Non-prophylactic clipping (non-PC)
Number of subjects: 1080
Study: 32360105

Group type: EXPERIMENTAL
Intervention: Body weight‐adjustable treadmill
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Recumbent bike and use of a patterned electrical neuromuscular stimulation device
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Body weight‐adjustable treadmill and a patterned electrical neuromuscular stimulation device
Number of subjects: 363

Group type: COMPARATOR
Intervention: Stationary recumbent bike (control intervention)
Number of subjects: 363
Study: 34416294

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 798

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 798
Study: 32283941

Group type: EXPERIMENTAL
Intervention: Collar (N = 72)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Non-collar (N = 56)
Number of subjects: 128
Study: 35725362

Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non‐tourniquet group
Number of subjects: 80
Study: 35175908

Group type: EXPERIMENTAL
Intervention: Teach-back method for breastfeeding education
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study: 34193288

Group type: EXPERIMENTAL
Intervention: e-cigarette
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both e-cigarette and NRT
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: STOP intervention
Number of subjects: 49
Study: 35312136

Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32620143

Group type: EXPERIMENTAL
Intervention: fructooligosaccharides
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: polydextrose
Number of subjects: 80
Study: 34027686

Group type: EXPERIMENTAL
Intervention: BAILAMOSTM dance program
Number of subjects: 57

Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 57
Study: 34040361

Group type: EXPERIMENTAL
Intervention: Stentoplasty with calcium sulfate/calcium phosphate (CSCP) composite filler
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Stentoplasty with hydroxyapatite/collagen (HAP/COL) composite filler
Number of subjects: 42

Group type: COMPARATOR
Intervention: Balloon kyphoplasty (BKP) with polymethylmethacrylate (PMMA)
Number of subjects: 42
Study: 32533295

Group type: EXPERIMENTAL
Intervention: Internet-Delivered Parent-Child Interaction Therapy (iPCIT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard, clinic-based Parent-Child Interaction Therapy (PCIT)
Number of subjects: 40
Study: 616222542

Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg bid
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg bid
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 35904308

Group type: EXPERIMENTAL
Intervention: Telehealth supervised home core stabilization program for 8 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: No exercise (Control group)
Number of subjects: 54
Study: 33461559

Group type: EXPERIMENTAL
Intervention: SPOTLIGHT Virtual Audit Tool (S‐VAT)
Number of subjects: 148
Study: 32278637

Group type: EXPERIMENTAL
Intervention: RFA with compression stocking for two weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: RFA alone
Number of subjects: 100
Study: 34525968

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 0
Study: 36274681

Group type: EXPERIMENTAL
Intervention: Mixture of autologous adipose-derived stem cells (ASCs) and platelet rich plasma (PRP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Enamel matrix derivative administration
Number of subjects: 15
Study: 32947142

Group type: EXPERIMENTAL
Intervention: Uterine-preserving surgery
Number of subjects: 77

Group type: COMPARATOR
Intervention: Non-uterine-preserving surgery
Number of subjects: 77
Study: 35672455

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Exercise training (12-week program)
Number of subjects: 26
Study: 34916634

Group type: EXPERIMENTAL
Intervention: Minimal split-thickness envelope flap (test group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Flap with no vertical releasing incision (control group)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 28
Study: 34910230

Group type: EXPERIMENTAL
Intervention: Short-term preoperative drainage (< 4 weeks)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Long-term preoperative drainage (≥ 4 weeks)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Overall and recurrence-free survival rates
Number of subjects: 170
Study: 32737420

Group type: EXPERIMENTAL
Intervention: GnRH agonist
Number of subjects: 80

Group type: COMPARATOR
Intervention: GnRH antagonist
Number of subjects: 80
Study: 34982826

Group type: EXPERIMENTAL
Intervention: Explicit pain management instructions (Group B)
Number of subjects: 110

Group type: COMPARATOR
Intervention: General pain management instructions (Group A)
Number of subjects: 110
Study: 32969531

Group type: EXPERIMENTAL
Intervention: N95 respirator
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 16

Group type: COMPARATOR
Intervention: No mask
Number of subjects: 16
Study: 36286657

Group type: EXPERIMENTAL
Intervention: Acveris
Number of subjects: 28

Group type: COMPARATOR
Intervention: Soliris
Number of subjects: 28
Study: 34959861

Group type: EXPERIMENTAL
Intervention: Menthol (MEN)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination (BOTH)
Number of subjects: 8
Study: 35836365

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 33904820

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: In-person workshop
Number of subjects: 451

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 451
Study: 36463704

Group type: EXPERIMENTAL
Intervention: Relaxation video
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Information video
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 142
Study: 33545934

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans LBSC, 6 billion/d for 80 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans LBSC
Number of subjects: 40
Study: 34315232

Group type: EXPERIMENTAL
Intervention: Clinical decision support system
Number of subjects: 1145

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1145
Study: 35732969

Group type: EXPERIMENTAL
Intervention: Juvenile Drug Treatment Courts (JDTC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional Juvenile Court (TJC)
Number of subjects: 10
Study: 35164524

Group type: EXPERIMENTAL
Intervention: Lithium plus antipsychotics (Li+AP) (N = 50, primarily quetiapine and aripiprazole)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Lithium only (control group) (N = 149)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Lithium plus anticonvulsants (Li+AC) (N = 107, primarily lamotrigine and valproate)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Lithium plus antipsychotics and anticonvulsants (Li+AP+AC) (N = 73)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Lithium plus antipsychotics (Li+AP)
Number of subjects: 379
Study: 34449859

Group type: EXPERIMENTAL
Intervention: Novel ultrasound device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional ultrasound device
Number of subjects: 40
Study: 32430189

Group type: EXPERIMENTAL
Intervention: YouGrabber (YG) virtual reality training system
Number of subjects: 5
Study: 35604687

Group type: EXPERIMENTAL
Intervention: Acupoint hot compress (3 sessions of 4 hours each within 30 minutes, 24 hours, and 48 hours after delivery)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Acupoint hot compress
Number of subjects: 1200
Study: 33040675

Group type: EXPERIMENTAL
Intervention: Pharmacist-led interventions
Number of subjects: 65
Study: 35242728

Group type: EXPERIMENTAL
Intervention: WhatsApp-based intervention for continued learning
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 208
Study: 32044039

Group type: EXPERIMENTAL
Intervention: Motor Learning (ML) Group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) Group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Robotics Group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study: 35383052

Group type: EXPERIMENTAL
Intervention: HIV/TB syndemic impact on attitudes towards TB screening
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: HIV/TB syndemic impact on attitudes towards TB treatment
Number of subjects: 820
Study: 34481111

Group type: EXPERIMENTAL
Intervention: PROERD intervention (ten classes taught by trained police officers)
Number of subjects: 4030

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4030
Study: 32290852

Group type: EXPERIMENTAL
Intervention: 1000 mg/day synbiotic (Familact) for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 72
Study: 33634375

Group type: EXPERIMENTAL
Intervention: Brief in-home intervention targeting parenting skills
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard pediatric primary care
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Behaviorally-based parenting skills
Number of subjects: 58
Study: 33510315

Group type: EXPERIMENTAL
Intervention: Labyrinth‐VR (12 hours of computer game play over four weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo control game (12 hours of computer game play over four weeks)
Number of subjects: 48
Study: 32641374

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG)
Number of subjects: 161
Study: 35422467

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lamotrigine (pre-treatment)
Number of subjects: 0
Study: 33640422

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) (25 Gy in 10 fractions)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 84
Study: 36364756

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei IJH-SONE68 fermented pineapple juice
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32555927

Group type: EXPERIMENTAL
Intervention: Levosimendan (12 µg/kg bolus)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (routine treatment only)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Levosimendan and Control
Number of subjects: 49
Study: 36353052

Group type: EXPERIMENTAL
Intervention: TACmono
Number of subjects: 121

Group type: COMPARATOR
Intervention: TAC/MMF
Number of subjects: 121
Study: 33781980

Group type: EXPERIMENTAL
Intervention: Low-temperature electrocautery
Number of subjects: 5641

Group type: COMPARATOR
Intervention: Standard electrocautery
Number of subjects: 5641
Study: 34265389

Group type: EXPERIMENTAL
Intervention: NoCL (patients without unstable chondral lesions)
Number of subjects: 118

Group type: COMPARATOR
Intervention: CL-noDeb (patients with unstable chondral lesions)
Number of subjects: 118
Study: 34965784

Group type: EXPERIMENTAL
Intervention: Resourcefulness intervention (teaching on social and personal resourcefulness skills, access to intervention video, skill application video-vignettes, four weeks of skills reinforcement using daily logs, four weekly phone contacts, booster sessions at two- and four-month postenrollment)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Attention control (phone contact at identical time points plus the current standard of care)
Number of subjects: 93
Study: 33247707

Group type: EXPERIMENTAL
Intervention: Arglabin
Number of subjects: 0

Group type: COMPARATOR
Intervention: AC regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AC + Arglabin
Number of subjects: 0
Study: 35011093

Group type: EXPERIMENTAL
Intervention: Lemon verbena (Lippia citriodora) extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32769645

Group type: EXPERIMENTAL
Intervention: Surgical repair of pelvic organ prolapse (including transvaginal native tissue repairs, transvaginal mesh or graft-augmented repairs, abdominal sacrocolpopexy)
Number of subjects: 932

Group type: EXPERIMENTAL
Intervention: Baseline dyspareunia
Number of subjects: 932
Study: 36126369

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 198
Study: 33804123

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Number of subjects: 187

Group type: COMPARATOR
Intervention: Delayed treatment (Control)
Number of subjects: 187
Study: 33597157

Group type: EXPERIMENTAL
Intervention: Hydrothermal duodenal mucosal resurfacing (DMR)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 108
Study: 33734306

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (2 mg) quarterly for 24 months
Number of subjects: 127

Group type: COMPARATOR
Intervention: Sham injection quarterly for 24 months
Number of subjects: 127
Study: 32501541

Group type: EXPERIMENTAL
Intervention: IM doravirine 200 mg (Treatment A: 1×1 mL, 20% suspension)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IM doravirine 300 mg (Treatment B: 1×0.66 mL, 30% suspension)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IM doravirine 200 mg (Treatment C: 2×0.5 mL, 20% suspension)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Oral doravirine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IM doravirine
Number of subjects: 36
Study: 35501626

Group type: EXPERIMENTAL
Intervention: Desktop Virtual Reality (VR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Face-to-Face Simulation with Simulated Patient (SP)
Number of subjects: 120
Study: 33270531

Group type: EXPERIMENTAL
Intervention: APEX system
Number of subjects: 15
Study: 36458387

Group type: EXPERIMENTAL
Intervention: Core stability training (five-week program, three days/week)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Regular training (control group)
Number of subjects: 70
Study: 32869659

Group type: EXPERIMENTAL
Intervention: Food insecurity
Number of subjects: 630
Study: 35627562

Group type: EXPERIMENTAL
Intervention: Marine therapy group (MTG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study: 616759071

Group type: EXPERIMENTAL
Intervention: Combination of beta‐TCP and rhGDF‐5 (400 mug)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of beta‐TCP and rhGDF‐5 (800 mug)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (beta‐TCP only)
Number of subjects: 12
Study: 35321886

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sodium chloride infusion (placebo)
Number of subjects: 9
Study: 34903696

Group type: EXPERIMENTAL
Intervention: 12-month lifestyle intervention
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study: 35660485

Group type: EXPERIMENTAL
Intervention: Algorithm-based FiO2 titration with electronic medical record-based automated alerts
Number of subjects: 316

Group type: COMPARATOR
Intervention: Standard practice FiO2 titration
Number of subjects: 316
Study: 33388697

Group type: EXPERIMENTAL
Intervention: WM training
Number of subjects: 25

Group type: COMPARATOR
Intervention: Routine speech therapy (Control)
Number of subjects: 25
Study: 34549809

Group type: COMPARATOR
Intervention: sorafenib
Number of subjects: 987

Group type: COMPARATOR
Intervention: melphalan, prednisone, and thalidomide
Number of subjects: 987
Study: 33148299

Group type: EXPERIMENTAL
Intervention: Fire needle acupuncture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Filiform needle acupuncture
Number of subjects: 100
Study: 33507315

Group type: EXPERIMENTAL
Intervention: Ultrasound guided quadratus lumborum block (QLB) using 0.5 mL/kg body weight 0.25% bupivacaine preoperatively
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard postoperative analgesia protocol)
Number of subjects: 40